BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 22015458)

  • 1. Biliary infection may exacerbate biliary cystogenesis through the induction of VEGF in cholangiocytes of the polycystic kidney (PCK) rat.
    Ren XS; Sato Y; Harada K; Sasaki M; Yoneda N; Lin ZH; Nakanuma Y
    Am J Pathol; 2011 Dec; 179(6):2845-54. PubMed ID: 22015458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polycystic kidney rat is a novel animal model of Caroli's disease associated with congenital hepatic fibrosis.
    Sanzen T; Harada K; Yasoshima M; Kawamura Y; Ishibashi M; Nakanuma Y
    Am J Pathol; 2001 May; 158(5):1605-12. PubMed ID: 11337358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix proteins of basement membrane of intrahepatic bile ducts are degraded in congenital hepatic fibrosis and Caroli's disease.
    Yasoshima M; Sato Y; Furubo S; Kizawa K; Sanzen T; Ozaki S; Harada K; Nakanuma Y
    J Pathol; 2009 Feb; 217(3):442-51. PubMed ID: 19025978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of the PI3K/mTOR pathway is involved in cystic proliferation of cholangiocytes of the PCK rat.
    Ren XS; Sato Y; Harada K; Sasaki M; Furubo S; Song JY; Nakanuma Y
    PLoS One; 2014; 9(1):e87660. PubMed ID: 24498161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roles of myofibroblasts and notch and hedgehog signaling pathways in the formation of intrahepatic bile duct lesions in polycystic kidney rats.
    Furubo S; Sato Y; Harada K; Nakanuma Y
    Pediatr Dev Pathol; 2013; 16(3):177-90. PubMed ID: 23331119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blockade of Hedgehog Signaling Attenuates Biliary Cystogenesis in the Polycystic Kidney (PCK) Rat.
    Sato Y; Yamamura M; Sasaki M; Harada K
    Am J Pathol; 2018 Oct; 188(10):2251-2263. PubMed ID: 30036521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent progress in the etiopathogenesis of pediatric biliary disease, particularly Caroli's disease with congenital hepatic fibrosis and biliary atresia.
    Nakanuma Y; Harada K; Sato Y; Ikeda H
    Histol Histopathol; 2010 Feb; 25(2):223-35. PubMed ID: 20017109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of the MEK5/ERK5 cascade is responsible for biliary dysgenesis in a rat model of Caroli's disease.
    Sato Y; Harada K; Kizawa K; Sanzen T; Furubo S; Yasoshima M; Ozaki S; Ishibashi M; Nakanuma Y
    Am J Pathol; 2005 Jan; 166(1):49-60. PubMed ID: 15631999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholangiocytes with mesenchymal features contribute to progressive hepatic fibrosis of the polycystic kidney rat.
    Sato Y; Harada K; Ozaki S; Furubo S; Kizawa K; Sanzen T; Yasoshima M; Ikeda H; Sasaki M; Nakanuma Y
    Am J Pathol; 2007 Dec; 171(6):1859-71. PubMed ID: 18055542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of Toll-like receptors with bacterial components induces expression of CDX2 and MUC2 in rat biliary epithelium in vivo and in culture.
    Ikeda H; Sasaki M; Ishikawa A; Sato Y; Harada K; Zen Y; Kazumori H; Nakanuma Y
    Lab Invest; 2007 Jun; 87(6):559-71. PubMed ID: 17417665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of intrahepatic bile duct dilation of the polycystic kidney rat with a novel tyrosine kinase inhibitor gefitinib.
    Sato Y; Harada K; Furubo S; Kizawa K; Sanzen T; Yasoshima M; Ozaki S; Isse K; Sasaki M; Nakanuma Y
    Am J Pathol; 2006 Oct; 169(4):1238-50. PubMed ID: 17003482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cAMP effectors Epac and protein kinase a (PKA) are involved in the hepatic cystogenesis of an animal model of autosomal recessive polycystic kidney disease (ARPKD).
    Banales JM; Masyuk TV; Gradilone SA; Masyuk AI; Medina JF; LaRusso NF
    Hepatology; 2009 Jan; 49(1):160-74. PubMed ID: 19065671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue culture correlational study of genetic cholangiopathy of autosomal recessive polycystic kidney disease.
    Nakanuma Y; Sato Y; Harada K
    Methods Mol Biol; 2013; 945():303-18. PubMed ID: 23097114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic microcirculation and cholangiocyte physiopathology.
    Gaudio E; Onori P; Franchitto A; Pannarale L; Alpini G; Alvaro D
    Ital J Anat Embryol; 2005; 110(2 Suppl 1):71-5. PubMed ID: 16101023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of angiogenic factor overexpression by human and rodent cholangiocytes in polycystic liver diseases.
    Fabris L; Cadamuro M; Fiorotto R; Roskams T; Spirlì C; Melero S; Sonzogni A; Joplin RE; Okolicsanyi L; Strazzabosco M
    Hepatology; 2006 May; 43(5):1001-12. PubMed ID: 16628643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of Trpv4 reduces the hyperproliferative phenotype of cystic cholangiocytes from an animal model of ARPKD.
    Gradilone SA; Masyuk TV; Huang BQ; Banales JM; Lehmann GL; Radtke BN; Stroope A; Masyuk AI; Splinter PL; LaRusso NF
    Gastroenterology; 2010 Jul; 139(1):304-14.e2. PubMed ID: 20399209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ursodeoxycholic acid inhibits hepatic cystogenesis in experimental models of polycystic liver disease.
    Munoz-Garrido P; Marin JJ; Perugorria MJ; Urribarri AD; Erice O; Sáez E; Úriz M; Sarvide S; Portu A; Concepcion AR; Romero MR; Monte MJ; Santos-Laso Á; Hijona E; Jimenez-Agüero R; Marzioni M; Beuers U; Masyuk TV; LaRusso NF; Prieto J; Bujanda L; Drenth JP; Banales JM
    J Hepatol; 2015 Oct; 63(4):952-61. PubMed ID: 26044126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of metalloprotease hyperactivity in cystic cholangiocytes halts the development of polycystic liver diseases.
    Urribarri AD; Munoz-Garrido P; Perugorria MJ; Erice O; Merino-Azpitarte M; Arbelaiz A; Lozano E; Hijona E; Jiménez-Agüero R; Fernandez-Barrena MG; Jimeno JP; Marzioni M; Marin JJ; Masyuk TV; LaRusso NF; Prieto J; Bujanda L; Banales JM
    Gut; 2014 Oct; 63(10):1658-67. PubMed ID: 24436140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ischemia reperfusion of the hepatic artery induces the functional damage of large bile ducts by changes in the expression of angiogenic factors.
    Mancinelli R; Glaser S; Francis H; Carpino G; Franchitto A; Vetuschi A; Sferra R; Pannarale L; Venter J; Meng F; Alpini G; Onori P; Gaudio E
    Am J Physiol Gastrointest Liver Physiol; 2015 Dec; 309(11):G865-73. PubMed ID: 26451003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and characterization of a cholangiocyte cell line from the PCK rat, an animal model of Autosomal Recessive Polycystic Kidney Disease.
    Muff MA; Masyuk TV; Stroope AJ; Huang BQ; Splinter PL; Lee SO; Larusso NF
    Lab Invest; 2006 Sep; 86(9):940-50. PubMed ID: 16783394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.